Plerixafor MSN

GIF decision: Marketing suspension

What does this decision mean?

  • Wstrzymanie w obrocie — The product has been temporarily suspended from circulation — sales are paused pending clarification, but it is not a full market recall.

Tests by the National Medicines Institute showed that the product fails quality requirements due to contamination with particles visible to the naked eye in the solution for injection. Potential effects: complications after intravenous or subcutaneous use, inflammatory reactions, embolism, life-threatening events.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Plerixafor MSN
Risk Level
Critical
Manufacturer
MSN Labs Europe Limited
Batch Number
CSE02010H
Notice Date
29.01.2026
View official statement

Related

Other Notices